Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-30T05:46:29.017Z Has data issue: false hasContentIssue false
  • English
  • Français

EPA-1607 - Underlying Mechanisms of Placebo Effect. an Integrative View

Published online by Cambridge University Press:  15 April 2020

E. Gimeno  and
P. Ruisoto
E. Gimeno
Affiliation:
Department of Basic Psychology Psychobiology and Methodology of Behavioral Sciences., University of Salamanca Salamanca Spain., Salamanca, Spain
P. Ruisoto
Affiliation:
Department of Basic Psychology Psychobiology and Methodology of Behavioral Sciences., University of Salamanca Salamanca Spain., Salamanca, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Placebo effect has been a controversial and hot topic within psychoneuroinmunology. However recent studies have shed considerable light on the potential mechanisms of placebo responses and their role in health outcomes.

Aim and objectives

This study aims to provide a new and integrative look at the neurobiological mechanisms underlying the placebo effect.

Methods

A systematic review was conducted for articles published in peer-review journals in the last decade.

Results

The two most evidence-based neural pathways for placebo effect: dopamine-related and endorphine-related; are fully explained and integrated in a comprehensive view.

Conclusions

The placebo effect represents an example of well-documented mind effect on the body. Implications for stress-related diseases are discussed.

Type
P25 - Psychoneuroimmunology
Information
European Psychiatry , Volume 29 , Issue S1: Abstracts of the 22nd European Congress of Psychiatry , 2014 , pp. 1
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.